Experimental Drug Development Centre (Eddc) company information, Employees & Contact Information

Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) PR Newswire

Singapore's EDDC receives US FDA Fast Track Designation for Antibody-Drug Conjugate BioSpectrum Asia

Leveraging Structural and Computational Biology for Molecular Glue Discovery ACS Publications

Engine Biosciences and Experimental Drug Development Centre Partner to Advance Novel Therapies to Combat Cancer PR Newswire

Sprint Bioscience and EDDC collaborate to evaluate MASH programme therapeutic compounds BioSpectrum Asia

First made-in-Singapore antibody-drug conjugate EBC-129 progresses to phase 1B dose expansion EurekAlert!

ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics Business Wire

Phase 1 trial for EBC-129 progresses into dose expansion News-Medical

Updated data from Phase I study of antibody-drug conjugate EBC-129 released Medical Xpress

ImmunoScape and EDDC partner to develop TCR-based therapeutics Pharmaceutical Technology

First Made-in-Singapore Antibody-drug Conjugate Approved To Enter Clinical Trials Agency for Science, Technology and Research

Identification of small-molecule binding sites of a ubiquitin-conjugating enzyme-UBE2T through fragment-based screening Wiley Online Library

An Evolving Landscape of Small Molecules Targeting SARS-CoV-2: What Are We Awaiting Beyond 3CLpro Inhibitors? ACS Publications

XtalPi and EDDC Sign New Collaboration, Empowering Biomedical Innovation with Robotics and Large Language Models PR Newswire

How Singapore Punches Above Its Weight In Advancing Drug Discovery And Development Agency for Science, Technology and Research

BOEHRINGER INGELHEIM ENTERS GLOBAL LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE INNOVATIVE ANTIBODIES FROM A*STAR FOR TARGETED CANCER THERAPIES Business Wire

ImmunoScape & Experimental Drug Development Centre ink cell therapy partnership in Singapore BioSpectrum Asia

Everest Medicines to develop, commercialise EDDC’s small molecules as potential COVID-19 oral antiviral treatments Agency for Science, Technology and Research

Crossing The Valley Of Death In Drug Discovery And Development Agency for Science, Technology and Research

EDDC and Hummingbird Bioscience Enter Into Partnership to Co-Develop Novel Antibodies for Cancer Treatment Agency for Science, Technology and Research

US-based Neuro-Horizon Pharma licenses promising compounds from NTU Singapore to combat multidrug-resistant tuberculosis EurekAlert!

Licensing agreement with Boehringer Ingelheim to develop and commercialize cancer antibodies Agency for Science, Technology and Research

PDAC antibody-drug conjugate EBC-129 wins FDA fast track status Rare Cancer News

BioCurate Announces Strategic Alliance with the Experimental Drug Development Centre in Singapore BioMelbourne Network

Singapore’s drug development efforts given additional momentum with national platforms Agency for Science, Technology and Research

EDDC and NTU develop novel drug candidates to combat deadly, ancient disease Agency for Science, Technology and Research

Experimental Drug Development Centre Reveals Updated Phase 1 Data on Bioengineer.org

EDDC discovers small molecule inhibitors for COVID-19 and other coronavirus infections Agency for Science, Technology and Research

Singapore deepens research collaboration in applied AI for drug discovery and life sciences BioSpectrum Asia

Spin-off to Develop Targeted Protein Degraders for Treating Intractable Diseases Agency for Science, Technology and Research

APAC takes centre-stage in AI-driven drug discovery BioSpectrum Asia

Made-in-Singapore cancer drug etc-159 advances further in clinical trials Agency for Science, Technology and Research

Scholarship propels her career beyond the lab to biotech business development Agency for Science, Technology and Research

Cancer drug ETC-159 reaches new milestone in clinical trials Agency for Science, Technology and Research

From Singapore to the world: Where Fortitude Kit has been deployed globally Agency for Science, Technology and Research

Antimicrobial Resistance and Antibacterial Drug Discovery | Institute of Advanced Studies | NTU Singapore Nanyang Technological University - NTU Singapore

Singapore Confers Honorary Citizen Award On A*STAR Board Member Professor William Chin Agency for Science, Technology and Research

HHP I&E Workplan Sharing Agency for Science, Technology and Research

RSPO Agency for Science, Technology and Research

Mapping the Undiscovered Agency for Science, Technology and Research

Antimicrobial Resistance, Intellectual Property and Early-Stage Drug Development by Prof Thomas Dick , Dr Vladimir Marshansky & Dr Mhairi Skinner | Institute of Advanced Studies | NTU Singapore Nanyang Technological University - NTU Singapore

DPM Heng Swee Keat at Opening of Hummingbird Bioscience at Galen Building pmo.gov.sg

FIGHTING COVID-19 WITH FORTITUDE Agency for Science, Technology and Research

Singapore pharma sector an 'increasingly important' part of manufacturing: Fitch The Straits Times